Molecular Partners (MOLN) Short Interest Ratio & Short Volume $3.64 -0.17 (-4.54%) Closing price 10/28/2026 03:59 PM EasternExtended Trading$3.61 -0.03 (-0.71%) As of 04:01 AM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more. Add Compare Share Share Short Interest Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsNews and TrendsOwnershipSEC FilingsShort Interest Molecular Partners Short Interest OverviewAs of October 15, 2026, Molecular Partners (MOLN) had a short interest of 580 shares sold short, representing 0.00% of the public float. This marks a 134.82% increase in short interest since the prior report. The short interest ratio (days to cover) is 0.3, meaning it would take 0.3 days of the average trading volume of 4,336 shares to cover all short positions.Current Short Interest580 sharesPrevious Short Interest247 sharesChange Vs. Previous Month134.82%Dollar Volume Sold Short$2.17 thousandShort Interest Ratio0.3 Days to CoverLast Record DateOctober 15, 2026Outstanding Shares40,375,000 sharesShort Percent of Float0.00%Today's Trading Volume1,759 sharesAverage Trading Volume4,336 sharesToday's Volume Vs. Average41% Short Selling Molecular Partners? Sign up to receive the latest short interest report for Molecular Partners and its competitors with MarketBeat's FREE newsletter. Email Address Get Report View SMS TermsSMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. Skip Charts & View Short Interest HistoryShort Interest ChartDays to Cover ChartShort Percent of Float ChartMOLN Short Interest Over TimeMOLN Days to Cover Over TimeMOLN Percentage of Float Shorted Over Time Molecular Partners Tesla Short Interest History & Recent Changes ExportReport DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date 10/15/2026580 shares $2.17 thousand +134.8%0.0%0.32 $3.75 9/30/2026247 shares $968.73 +13.3%0.0%0.18 $3.92 9/15/2026218 shares $915.16 -0.5%0.0%0.21 $4.20 8/31/2026219 shares $959.22 +17.1%0.0%0.13 $4.38 8/14/2026187 shares $767.64 -86.5%0.0%0.18 $4.11 7/31/20261,385 shares $5.61 thousand -49.3%0.0%1.75 $4.05 7/15/20262,733 shares $11.16 thousand +56.1%0.0%0.28 $4.08 6/30/20261,751 shares $6.78 thousand -84.3%0.0%0.17 $3.87 6/15/202611,177 shares $42.86 thousand +9.7%0.0%2.59 $3.84 5/29/202610,189 shares $41.52 thousand +67.9%0.0%1.3 $4.08 Get the Latest News and Ratings for MOLN and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Molecular Partners and its competitors with MarketBeat's FREE daily newsletter. 5/15/20266,068 shares $22.97 thousand -38.6%0.0%1.16 $3.79 4/30/20269,883 shares $41.81 thousand -23.3%0.0%4.97 $4.23 4/15/202612,887 shares $54.00 thousand -20.4%0.0%3.54 $4.19 3/31/202616,194 shares $64.29 thousand +15.7%0.0%4.13 $3.97 3/13/202613,996 shares $59.06 thousand -18.9%0.0%4.38 $4.22 2/27/202617,248 shares $86.58 thousand +7.5%0.0%7.09 $5.02 2/13/202616,044 shares $72.90 thousand -2.2%0.0%4.41 $4.54 1/30/202616,410 shares $69.74 thousand +2.7%0.0%2.24 $4.25 1/15/202615,985 shares $67.54 thousand -4.3%0.0%3.47 $4.23 12/31/202516,697 shares $74.22 thousand -17.9%0.0%4.23 $4.45 12/15/202520,342 shares $83.32 thousand -23.0%0.1%4.94 $4.10 11/28/202526,423 shares $107.91 thousand +8.6%0.1%15.87 $4.08 11/14/202524,337 shares $104.89 thousand +0.7%0.1%1.26 $4.31 10/31/202524,180 shares $89.59 thousand -16.8%0.1%19.34 $3.71 10/15/202529,100 shares $108.57 thousand -16.1%0.1%10 $3.73 9/30/202534,700 shares $128.74 thousand +17.6%0.1%12.4 $3.71 9/15/202529,500 shares $110.77 thousand +6.9%0.1%10.9 $3.76 8/31/202527,600 shares $105.57 thousand -10.4%0.1%11 $3.83 8/15/202530,800 shares $108.88 thousand -2.2%0.1%11.8 $3.54 7/31/202531,500 shares $115.95 thousand -3.1%0.1%16.6 $3.68 7/15/202532,500 shares $115.47 thousand -3.9%0.1%3.5 $3.55 6/30/202533,800 shares $128.10 thousand -5.1%0.1%3.4 $3.79 6/15/202535,600 shares $137.81 thousand -10.6%0.1%3.5 $3.87 5/31/202539,800 shares $155.38 thousand -13.9%0.1%3.8 $3.90 5/15/202546,200 shares $177.45 thousand -9.8%0.1%4.4 $3.84 4/30/202551,200 shares $199.68 thousand +33.0%0.1%5 $3.90 4/15/202538,500 shares $144.57 thousand -1.8%0.1%5.5 $3.76 3/31/202539,200 shares $160.52 thousand -3.0%0.1%9.8 $4.10 3/15/202540,400 shares $175.34 thousand -6.3%0.1%10.1 $4.34 2/28/202543,100 shares $216.79 thousand +1.2%0.1%5.3 $5.03A Simple Guide to Options Trading While It's Still Free (Ad)A free copy of Options Trading Made Simple is available now but wont stay that way for long. Chris Rowe calls it The 10-Minute Guide to Start Trading Options Today, built to help you open your first options trade with less capital than buying shares outright.Download your free copy of Options Trading Made Simple before it's gone 2/15/202542,600 shares $209.59 thousand -8.2%0.1%3.9 $4.92 1/31/202546,400 shares $247.73 thousand +3.6%0.1%3.5 $5.34 1/15/202544,800 shares $258.94 thousand -10.4%0.1%2.6 $5.78 12/31/202450,000 shares $237.50 thousand +2.5%0.1%2.1 $4.75 12/15/202448,800 shares $264.98 thousand -10.8%0.1%2 $5.43 11/30/202454,700 shares $318.35 thousand -5.7%0.2%2.3 $5.82 11/15/202458,000 shares $309.14 thousand +1.6%N/A3.2 $5.33 10/31/202457,100 shares $310.62 thousand +70.5%N/A3.5 $5.44 10/15/202433,500 shares $165.83 thousand +7.4%N/A1.4 $4.95 9/30/202431,200 shares $158.72 thousand +4.4%N/A1.9 $5.09 9/15/202429,900 shares $156.08 thousand +0.3%N/A1.7 $5.22 8/31/202429,800 shares $169.26 thousand -8.9%N/A0.8 $5.68 8/15/202432,700 shares $206.89 thousand -53.2%N/A0.9 $6.33 7/31/202469,900 shares $629.10 thousand +6.2%N/A1.9 $9.00 7/15/202465,800 shares $413.88 thousand -23.8%N/A2.4 $6.29 6/30/202486,300 shares $623.95 thousand -25.1%N/A3.2 $7.23 6/15/2024115,200 shares $779.90 thousand +134.2%N/A4.6 $6.77 5/31/202449,200 shares $177.12 thousand No ChangeN/A7.5 $3.60 5/15/202449,200 shares $182.53 thousand -8.0%N/A13.7 $3.71 4/30/202453,500 shares $202.28 thousand -5.1%N/A15.7 $3.78 4/15/202456,400 shares $222.78 thousand +17.8%N/A18.8 $3.95 3/31/202447,900 shares $201.18 thousand -2.2%N/A9.8 $4.20 3/15/202449,000 shares $194.04 thousand -12.5%N/A3.7 $3.96 2/29/202456,000 shares $240.80 thousand -7.6%N/A4.1 $4.30 2/15/202460,600 shares $282.09 thousand +3.6%N/A4.5 $4.66 1/31/202458,500 shares $279.63 thousand -13.7%N/A4.4 $4.78 1/15/202467,800 shares $323.41 thousand +1,132.7%N/A4.9 $4.77 12/31/20235,500 shares $22.99 thousand -11.3%N/A0.4 $4.18 12/15/20236,200 shares $26.10 thousand -39.2%N/A2.4 $4.21 11/30/202310,200 shares $42.84 thousand +117.0%N/A2.6 $4.20 11/15/20234,700 shares $20.77 thousand -4.1%N/A1 $4.42 10/31/20234,900 shares $17.30 thousand +2.1%N/A0.9 $3.53 10/15/20234,800 shares $20.88 thousand -34.3%N/A1 $4.35 9/30/20237,300 shares $30.22 thousand -73.1%N/A1.6 $4.14 9/15/202327,100 shares $123.58 thousand +173.7%N/A6 $4.56 8/31/20239,900 shares $59.30 thousand +135.7%N/A3.5 $5.99 8/15/20234,200 shares $24.82 thousand +23.5%N/A2.1 $5.91 7/31/20233,400 shares $20.35 thousand +21.4%N/A2.6 $5.99 7/15/20232,800 shares $18.31 thousand -46.2%N/A2.3 $6.54 6/30/20235,200 shares $32.34 thousand -3.7%N/A4 $6.22 6/15/20235,400 shares $35.75 thousand +54.3%N/A4.2 $6.62 5/31/20233,500 shares $22.47 thousand -31.4%N/A2.1 $6.42 5/15/20235,100 shares $33.76 thousand -42.7%N/A3.6 $6.62 4/30/20238,900 shares $58.65 thousand -60.4%N/A4.9 $6.59 4/15/202322,500 shares $146.93 thousand +9.2%N/A10.2 $6.53 3/31/202320,600 shares $124.38 thousand +32.1%N/A9.4 $6.04 3/15/202315,600 shares $91.42 thousand +2.6%N/A6.2 $5.86 2/28/202315,200 shares $95 thousand No ChangeN/A4.8 $6.25 2/15/202315,200 shares $97.58 thousand -2.6%N/A4.5 $6.42 1/31/202315,600 shares $100.62 thousand -1.3%N/A3 $6.45First Look: Elon’s “Starphone” (Ad)Rumors are swirling that Elon Musk is developing a new mobile device that could rival the iPhone. It's said to be thinner, longer-lasting on battery, and cheaper to produce, with the ability to work worldwide without relying on cell towers. Former Bloomberg reporter and SAC Capital trader Josh Baylin says the evidence is mounting. He notes the FCC recently gave Musk a green light connected to his mobile plans, adding fuel to speculation. Baylin previously called the smartphone boom in 2004 and predicted Apple would sell a billion phones when others expected a fraction of that.See the full evidence behind Elon Musk's rumored new device. 1/15/202315,800 shares $107.48 thousand +22.5%N/A2.8 $6.80 12/30/202212,900 shares $84.50 thousand +10.3%N/A1.7 $6.55 12/15/202211,700 shares $80.03 thousand -14.0%N/A1.4 $6.84 11/30/202213,600 shares $87.04 thousand +9.7%N/A1.5 $6.40 11/15/202212,400 shares $86.06 thousand -2.4%N/A1.3 $6.94 10/31/202212,700 shares $79.12 thousand -7.3%N/A1.3 $6.23 10/15/202213,700 shares $83.43 thousand -12.7%N/A1.5 $6.09 9/30/202215,700 shares $105.03 thousand -20.7%N/A1.7 $6.69 9/15/202219,800 shares $124.94 thousand -26.4%N/A1.9 $6.31 8/31/202226,900 shares $157.63 thousand -9.4%N/A2 $5.86 8/15/202229,700 shares $201.66 thousand -34.3%N/A1.6 $6.79 7/31/202245,200 shares $279.79 thousand +5.6%N/A1.6 $6.19 7/15/202242,800 shares $270.50 thousand -3.4%N/A1.4 $6.32 6/30/202244,300 shares $300.35 thousand +13.3%N/A1.5 $6.78 6/15/202239,100 shares $265.49 thousand +141.4%N/A1.4 $6.79 5/31/202216,200 shares $123.12 thousand +76.1%N/A0.6 $7.60 5/15/20229,200 shares $63.48 thousand -47.4%N/A0.4 $6.90 4/30/202217,500 shares $140.88 thousand +14.4%N/A1.8 $8.05 4/15/202215,300 shares $292.23 thousand -26.8%N/A1.4 $19.10 3/31/202220,900 shares $429.50 thousand -54.5%N/A0.5 $20.55 3/15/202245,900 shares $941.41 thousand -26.7%N/A1 $20.51 2/28/202262,600 shares $1.51 million -19.4%N/A1.3 $24.15 2/15/202277,700 shares $2.05 million -5.0%N/A1.5 $26.37 1/31/202281,800 shares $2.24 million -40.3%N/A1.4 $27.35 1/15/2022137,000 shares $4.37 million +1,081.0%N/A2.4 $31.89 12/31/202111,600 shares $222.49 thousand -32.6%N/A0.4 $19.18 12/15/202117,200 shares $270.04 thousand +45.8%N/A0.6 $15.70 11/30/202111,800 shares $165.32 thousand -19.2%N/A0.5 $14.01 11/15/202114,600 shares $215.93 thousand +78.1%N/A0.7 $14.79 10/29/20218,200 shares $152.60 thousand -6.8%N/A0.4 $18.61 MOLN Short Interest - Frequently Asked Questions What is Molecular Partners' current short interest? Short interest is the volume of Molecular Partners shares that have been sold short but have not yet been covered or closed out. As of October 15th, investors have sold 580 shares of MOLN short. 0.00% of Molecular Partners' shares are currently sold short. Learn More on Molecular Partners' current short interest. What is a good short interest ratio for Molecular Partners? The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. MOLN shares currently have a short interest ratio of 0.3. Learn More on Molecular Partners's short interest ratio. What is a good short interest percentage for Molecular Partners? Companies that have a short interest as a percentage of float below 10% indicates positive investor sentiment and few short sellers. Stocks with a short interest percentage above 10% is considered high, suggesting some investors are pessimistic about the stock. Companies with a short interest percentage of 20% or more indicates widespread negative sentiment. 0.00% of Molecular Partners' floating shares are currently sold short. Is Molecular Partners' short interest increasing or decreasing? Molecular Partners saw a increase in short interest in October. As of October 15th, there was short interest totaling 580 shares, an increase of 134.8% from the previous total of 247 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment. How does Molecular Partners' short interest compare to its competitors? 0.00% of Molecular Partners' shares are currently sold short. Here is how the short interest of companies in the industry of "biotechnology" compare to Molecular Partners: DBV Technologies S.A. (1.40%), Shattuck Labs, Inc. (11.41%), Puma Biotechnology, Inc. (11.31%), CytomX Therapeutics, Inc. (20.41%), Valneva SE Sponsored ADR (0.24%), Sensei Biotherapeutics, Inc. (9.66%), Myriad Genetics, Inc. (9.88%), Aclaris Therapeutics, Inc. (11.29%), Entera Bio Ltd. (3.31%), Neurogene Inc. (28.82%), Which stocks are the most shorted right now? As of the most recent reporting period, the following stocks had the largest short interest positions: SPDR S&P 500 ETF Trust ($71.77 billion), Invesco QQQ ($59.70 billion), iShares Russell 2000 ETF ($23.54 billion), Medtronic PLC ($13.33 billion), SPDR S&P Biotech ETF ($10.47 billion), iShares iBoxx $ High Yield Corporate Bond ETF ($10.36 billion), Nebius Group N.V. ($8.98 billion), iShares 20+ Year Treasury Bond ETF ($8.92 billion), iShares iBoxx $ Investment Grade Corporate Bond ETF ($8.10 billion), and iShares Semiconductor ETF ($7.74 billion). View all of the most shorted stocks. What does it mean to sell short Molecular Partners stock? Short selling MOLN is an investing strategy that aims to generate trading profit from Molecular Partners as its price is falling. MOLN shares are trading down $0.17 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit. How does a short squeeze work against Molecular Partners? A short squeeze for Molecular Partners occurs when it has a large amount of short interest and its stock increases in price. This forces short sellers to cover their short interest positions by buying actual shares of MOLN, which in turn drives the price of the stock up even further. How often is Molecular Partners' short interest reported? Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including MOLN, twice per month. The most recent reporting period available is October, 15 2026. What do MOLN's short interest metrics mean? Understanding short interest metrics can help you assess how traders are positioning around a stock like MOLN:Shares Sold Short: The total number of shares that have been sold by short sellers but have not yet been covered or closed out. A high number may indicate bearish sentiment.Short Float: The percentage of a company’s publicly available shares (or "float") that are sold short. A higher short float suggests a greater portion of the stock is being bet against.Days to Cover (Short Interest Ratio): This estimates how many days it would take short sellers to cover their positions, based on average daily trading volume. Higher values can signal potential for a short squeeze if buying pressure increases.These metrics are often used by traders to gauge sentiment, volatility risk, and the potential for price movements based on short covering activity. More Short Interest Resources from MarketBeat Related Companies DBV Technologies Short Squeeze Shattuck Labs Short Squeeze Puma Biotechnology Short Squeeze CytomX Therapeutics Short Squeeze Valneva Short Squeeze Sensei Biotherapeutics Short Squeeze Myriad Genetics Short Squeeze Aclaris Therapeutics Short Squeeze Entera Bio Short Squeeze Neurogene Short Squeeze Short Interest Tools Stocks to Short Largest Short Interest Positions Short Interest Increases Short Interest Decreases Short Interest Reporting Dates Short interest data for NASDAQ:MOLN is sourced from the Financial Industry Regulatory Authority (FINRA), with the most recent report published on 10/26/2026. FINRA publishes updated short interest twice a month. From Our PartnersThe cash in your checking account has a problemThere's a pile of cash sitting in your checking account, earning next to nothing while you weigh your options....Counterflow | SponsoredThe investigation Porter spent tens of thousands to documentPorter Stansberry flew the Porter and Co. team 3,300 miles to Dublin to investigate a 17-year investing experi...Porter & Company | SponsoredHere’s Why Trump Won’t End The Iran WarTrump has called an Iran deal close 38 times since the war began, yet the fighting keeps flaring back up. O...Banyan Hill Publishing | SponsoredA free stock pick, from me to youElon's paid this chip supplier since 2012. When NVIDIA tried to buy the company, he fought the deal. Withou...Behind the Markets | SponsoredManagement just bought 2.8 million sharesManagement just backed a $100 million buyback, repurchasing 2.8 million shares at an average price of $35.26 i...Monument Traders Alliance | SponsoredA Simple Guide to Options Trading While It's Still FreeA free copy of Options Trading Made Simple is available now but wont stay that way for long. Chris Rowe cal...True Market Insiders | SponsoredFinancial legend: “This is bad, really bad...”Dr. Martin D. Weiss has publicly predicted six major American market crashes over his 55-year career, each war...Weiss Ratings | SponsoredDon't lose access to thisIan Cooper's guide, 'The $50-to-$500 Options Strategy,' is still available for free download, but not for long...TradeWins | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Molecular Partners AG Sponsored ADR Please log in to your account or sign up in order to add this asset to your watchlist. Share Molecular Partners With A Colleague Link copied to clipboard. Unlock superior investment research and tools. Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools and reports. Get MarketBeat All Access MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.